Tag Archives: breast cancer

What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness

(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release

Genetic Study Reveals Potential for Tailored Breast Cancer Screening

(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could revolutionize breast cancer screening, potentially benefiting one in ten women. The study indicates that a comprehensive genetic risk profile could … Read the full press release

Roche’s Kadcyla Demonstrates Long-Term Survival Benefit in HER2-Positive Early Breast Cancer

(IN BRIEF) Roche has released positive long-term follow-up data from the Phase III KATHERINE study, evaluating Kadcyla® (trastuzumab emtansine) as adjuvant therapy for people with HER2-positive early-stage breast cancer (eBC) who have residual invasive disease following neoadjuvant treatment. The study … Read the full press release

AstraZeneca Presents Promising Data from Phase III Trials Advancing Cancer Treatments at ESMO Congress

(IN BRIEF) AstraZeneca has unveiled data from four pivotal Phase III trials at the European Society for Medical Oncology (ESMO) Congress, demonstrating advances in cancer treatments across multiple types of cancers. These trials include TROPION-Lung01 and TROPION-Breast01, showcasing the significance … Read the full press release

GSK Resolves California Zantac Litigation Through Confidential Settlements

(IN BRIEF) GlaxoSmithKline (GSK) has announced a confidential settlement in the Cantlay/Harper case filed in California state court, which was scheduled for trial in November 2023. Additionally, GSK has settled the three remaining breast cancer bellwether cases in California, effectively … Read the full press release

EIB Backs Polish company SDS Optic Inc. with €10 Million Investment in Cutting-Edge Cancer Detection Tech

(IN BRIEF) The European Investment Bank (EIB) has signed a €10 million loan agreement with Polish company SDS Optic Inc. to support the development and commercialization of their innovative cancer detection technology platform, inPROBE®. SDS Optic specializes in diagnostic and … Read the full press release

TechMed Researcher Annemieke Witteveen Nominated as Finalist for New Scientist Science Talent 2023

(IN BRIEF) Assistant Professor Annemieke Witteveen, from the Biomedical Signals and Systems department at the Faculty of EEMCS (TechMed Centre), has been nominated for the prestigious New Scientist Science Talent Prize. This award highlights emerging researchers, with Witteveen and 14 … Read the full press release

Researchers Develop Refined Mammography Method for Improved Breast Cancer Detection

(IN BRIEF) Researchers from the Paul Scherrer Institute (PSI) and ETH Zurich, along with the Baden Cantonal Hospital and University Hospital Zurich, have developed a refined method of mammography, an x-ray imaging technique used for detecting breast cancer. The new … Read the full press release

FDA Accepts AstraZeneca’s NDA for Capivasertib Combination Therapy in Advanced Breast Cancer

(IN BRIEF) AstraZeneca’s new drug application (NDA) for capivasertib, in combination with Faslodex, has been accepted and granted Priority Review by the US FDA for the treatment of advanced breast cancer. The NDA is being reviewed under Project Orbis, which … Read the full press release

M&S art installation “Sixteen” celebrates diversity and encourages breast health awareness

(IN BRIEF) M&S has unveiled an art installation called “Sixteen” on London’s South Bank. Created in partnership with female body casting artist Lydia Reeves, the installation showcases the chests of 16 M&S colleagues to normalise the uniqueness of breasts and … Read the full press release

STFC funds breast cancer detection research

SWINDON, 02-Nov-2018 — /EuropaWire/ — A collaboration of researchers from the UK is pursuing a technique to detect breast cancer more quickly, thanks to funding from STFC and partners. The consortium, led by De Montfort University Leicester (DMU) and the University … Read the full press release

Novartis: positive topline results from the global MONALEESA-7 trial

MONALEESA-7 met primary endpoint of progression-free survival, demonstrating superior efficacy of Kisqali combination therapy vs. endocrine treatment alone in first-line treatment of premenopausal women with HR+/HER2- advanced breast cancer[1]  Kisqali is the first CDK4/6 inhibitor to be studied in a Phase … Read the full press release

University of York Dr William Brackenbury to investigate how electrical charges help breast cancer spread

YORK, 21-Jul-2017 — /EuropaWire/ — A leading scientist at the University of York is to investigate whether a change in the electrical voltage of breast cancer cells could be helping them to spread around the body. Funded by charity Breast Cancer … Read the full press release

Radiologists can detect breast cancer when viewing a mammogram of the opposite breast, even when there is no visible abnormal lesion

New research by a psychologist at the University of York and colleagues at Brigham and Women’s Hospital in Boston, MA, US, and University of Leeds shows that radiologists can discriminate between normal and abnormal mammograms in half a second. YORK, … Read the full press release

The Lancet published new breast cancer clinical trial compared targeted radiotherapy during surgery with ZEISS INTRABEAM to traditional post-surgical radiotherapy treatment

5-year results of international TARGIT-A clinical trial support targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM as non-inferior to external beam radiotherapy (EBRT) for selected early stage breast cancer patients. Jena, Germany, 27-11-2013 — /EuropaWire/ — Results of the TARGIT-A clinical … Read the full press release